Ixekizumab improves outcomes of ankylosing spondylitis
November 05, 2018
Clinical trial summary results, Atul Deodhar, M.D., says “If ixekizumab is approved for the treatment of ankylosing spondylitis, it will would give physicians another option for patients, which is necessary.